Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles.

Saved in:
Bibliographic Details
Title: Oncogenic ETS fusions promote DNA damage and proinflammatory responses via pericentromeric RNAs in extracellular vesicles.
Authors: Ruzanov P; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Evdokimova V; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Pachva MC; Department of Molecular Oncology, British Columbia Cancer Research Centre and.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Minkovich A; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Zhang Z; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Langman S; Department of Molecular Oncology, British Columbia Cancer Research Centre and.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Gassmann H; Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany., Thiel U; Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany., Orlic-Milacic M; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Zaidi SH; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Peltekova V; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Heisler LE; Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Sharma M; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., Cox ME; Vancouver Prostate Centre, Vancouver, British Columbia, Canada., McKee TD; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Pathomics Inc., Toronto, Ontario, Canada., Zaidi M; Pathomics Inc., Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Lapouble E; Unité Génétique Somatique (UGS), Institut Curie, Centre Hospitalier Paris, France., McPherson JD; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Biochemistry and Molecular Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, California, USA., Delattre O; Unité Génétique Somatique (UGS), Institut Curie, Centre Hospitalier Paris, France.; Diversity and Plasticity of Childhood tumors, INSERM U830, Institut Curie Research Center, PSL Research University, Paris, France., Radvanyi L; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Immunology, University of Toronto, Toronto, Ontario, Canada., Burdach SE; Department of Molecular Oncology, British Columbia Cancer Research Centre and.; Department of Pediatrics, Children's Cancer Research Center, Kinderklinik München Schwabing, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.; CCC München Comprehensive Cancer Center, DKTK German Cancer Consortium, Munich, Germany.; Institute of Pathology, Translation Pediatric Cancer Research Action, School of Medicine, Technical University of Munich, Munich, Germany., Stein LD; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Sorensen PH; Department of Molecular Oncology, British Columbia Cancer Research Centre and.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Source: The Journal of clinical investigation [J Clin Invest] 2024 Mar 26; Vol. 134 (9). Date of Electronic Publication: 2024 Mar 26.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI169470